ClinicalTrials.govpublic full text
Pembrolizumab and Involved Site Radiation Therapy for Early Stage Relapsed or Primary Refractory Hodgkin Lymphoma
hodgkin lymphoma, pembrolizumab, radiation therapy, 17-054, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 838257
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.